Correction: Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography

被引：0
|
作者：
Shinsuke Uchikawa
Tomokazu Kawaoka
Hatsue Fujino
Atsushi Ono
Takashi Nakahara
Eisuke Murakami
Masami Yamauchi
Daiki Miki
Michio Imamura
Hiroshi Aikata
机构：
[1] Hiroshima University,Department of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences
来源：
Journal of Medical Ultrasonics | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 387
相关论文
共 50 条
  • [1] Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography
    Uchikawa, Shinsuke
    Kawaoka, Tomokazu
    Fujino, Hatsue
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Miki, Daiki
    Imamura, Michio
    Aikata, Hiroshi
    JOURNAL OF MEDICAL ULTRASONICS, 2023, 50 (01) : 57 - 62
  • [2] Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography
    Shinsuke Uchikawa
    Tomokazu Kawaoka
    Hatsue Fujino
    Atsushi Ono
    Takashi Nakahara
    Eisuke Murakami
    Masami Yamauchi
    Daiki Miki
    Michio Imamura
    Hiroshi Aikata
    Journal of Medical Ultrasonics, 2023, 50 : 57 - 62
  • [3] Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography (vol 50, pg 57, 2023)
    Uchikawa, Shinsuke
    Kawaoka, Tomokazu
    Fujino, Hatsue
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Miki, Daiki
    Imamura, Michio
    Aikata, Hiroshi
    JOURNAL OF MEDICAL ULTRASONICS, 2024, 51 (02) : 387 - 387
  • [4] Prediction of treatment response using contrast-enhanced ultrasonography in patients treated with Atezolizumab and Bevacizumab for unresectable hepatocellular carcinoma
    Takada, Hitomi
    Maekawa, Shinya
    Enomoto, Nobuyuki
    JOURNAL OF HEPATOLOGY, 2022, 77 : S387 - S387
  • [5] Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy
    Kudo, Masatoshi
    CANCERS, 2021, 13 (21)
  • [6] Sequential Therapy for Hepatocellular Carcinoma after Failure of Atezolizumab plus Bevacizumab Combination Therapy
    Kudo, Masatoshi
    LIVER CANCER, 2021, 10 (02) : 85 - 93
  • [7] A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
    Kudo, Masatoshi
    LIVER CANCER, 2020, 9 (02) : 119 - 137
  • [8] Evaluation of hepatocellular carcinoma using contrast-enhanced ultrasonography:correlation with microvessel morphology
    Ji-Dong Xiao
    Hepatobiliary & Pancreatic Diseases International, 2010, 9 (06) : 605 - 610
  • [9] Evaluation of hepatocellular carcinoma using contrast-enhanced ultrasonography: correlation with microvessel morphology
    Xiao, Ji-Dong
    Zhu, Wen-Hui
    Shen, Shou-Rong
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2010, 9 (06) : 605 - 610
  • [10] Evans’ syndrome induced by atezolizumab plus bevacizumab combination therapy in advanced hepatocellular carcinoma
    Masanori Fukushima
    Kazuaki Tajima
    Ryu Sasaki
    Yasuhiko Nakao
    Kosuke Takahashi
    Eisuke Ozawa
    Satoshi Miuma
    Takeharu Kato
    Hisamitsu Miyaaki
    Kazuhiko Nakao
    Clinical Journal of Gastroenterology, 2023, 16 : 402 - 406
12345